With more ADCs enter the clinic than ever before, it has never been more important to optimize clinical strategy to be able to demonstrate differentiation and benefit to oncology patients.

Join this session to follow the journey of ADC clinical development from early-to late-stage, spanning dose escalation, technologies and strategy for patient selection, and staying relevant in crowded target indications.